Zhang L Y, Lu L, Zhang L Y, Luo X G
J Anim Sci. 2016 Jun;94(6):2378-96. doi: 10.2527/jas.2016-0297.
Twenty-four organic Fe sources were evaluated by polarographic analysis and via solubility in buffers (pH 5 and 2) and deionized water. Organic Fe sources included 6 Fe-Met complexes (Fe-Met), 10 Fe-Gly complexes, 1 Fe-Lys complex, 4 Fe proteinates, and 3 Fe-AA complexes (Fe-AA). Sources varied considerably in chemical characteristics. Chelation strengths (quotient of formation [Q] values) ranged from weak (Q = 1.08) to extremely strong strength (Q = 8,590). A total of 1,170 1-d-old Arbor Acres male broilers were randomly allotted to 6 replicate cages (15 chicks/cage) for each of 13 treatments in a completely randomized design involving a 4 × 3 factorial arrangement of treatments (4 Fe sources × 3 added Fe levels) plus a control with no added Fe. Dietary treatments included a corn-soybean meal basal diet (control; 55.8 mg Fe/kg) and the basal diet supplemented with 20, 40, or 60 mg Fe/kg as iron sulfate (FeSO∙7HO); an Fe-Met with weak chelation strength (Fe-Met W; Q = 1.37; 14.7% Fe); an iron proteinate with moderate chelation strength (Fe-Prot M; Q = 43.6; 14.2% Fe); or an iron proteinate with extremely strong chelation strength (Fe-Prot ES; Q = 8,590; 10.2% Fe). The growth performance, Fe concentrations, hematological indices, and activities and gene expressions of 2 Fe-containing enzymes in tissues of broilers at 7, 14, and 21 d of age were determined in the present study. Transferrin saturation in plasma on 14 d; bone Fe on d 7 and 14; liver Fe on d 7, 14, and 21; kidney Fe on d 14; succinate dehydrogenase activities in the liver on d 21 and in the kidney on d 7 and 21; mRNA levels in the kidney and heart on d 14; and mRNA levels in the liver and kidney on d 21 linearly increased ( < 0.05) as added Fe levels increased. However, differences in bioavailabilities among Fe sources were detected ( < 0.05) only for the mRNA levels in the liver and kidney on d 21. Based on slope ratios from the multiple linear regression of mRNA level in the liver or kidney of broilers on d 21 on daily dietary analyzed Fe intake, the bioavailabilities of Fe-Met W, Fe-Prot M, and Fe-Prot ES relative to iron sulfate (100%) were 129 ( = 0.18), 164 ( < 0.003), and 174% ( < 0.001) or 102 ( = 0.95), 143 ( = 0.09), and 174% ( < 0.004), respectively. These results indicated that the relative bioavailabilities of organic Fe sources were closely related to their Q values and organic Fe sources with greater Q values showed higher Fe bioavailabilities.
通过极谱分析以及在缓冲液(pH 5和pH 2)和去离子水中的溶解度,对24种有机铁源进行了评估。有机铁源包括6种蛋氨酸铁络合物(Fe-Met)、10种甘氨酸铁络合物、1种赖氨酸铁络合物、4种蛋白铁以及3种氨基酸铁络合物(Fe-AA)。这些铁源在化学特性上差异很大。螯合强度(形成常数[Q]值)范围从弱(Q = 1.08)到极强(Q = 8590)。总共1170只1日龄的艾拔益加雄性肉鸡被随机分配到6个重复笼中(每个笼子15只雏鸡),采用完全随机设计,进行13种处理,其中包括4×3因子处理安排(4种铁源×3个添加铁水平)以及一个不添加铁的对照组。日粮处理包括玉米 - 豆粕基础日粮(对照组;55.8毫克铁/千克)以及添加了20、40或60毫克铁/千克硫酸亚铁(FeSO₄∙7H₂O)的基础日粮;一种螯合强度较弱的蛋氨酸铁(Fe-Met W;Q = 1.37;铁含量14.7%);一种螯合强度中等的蛋白铁(Fe-Prot M;Q = 43.6;铁含量14.2%);或一种螯合强度极强的蛋白铁(Fe-Prot ES;Q = 8590;铁含量10.2%)。本研究测定了7日龄、14日龄和21日龄肉鸡组织中的生长性能、铁浓度、血液学指标以及两种含铁酶的活性和基因表达。14日龄时血浆中转铁蛋白饱和度;7日龄和14日龄时骨骼中铁含量;7日龄、14日龄和21日龄时肝脏中铁含量;14日龄时肾脏中铁含量;21日龄时肝脏和7日龄及21日龄时肾脏中琥珀酸脱氢酶活性;14日龄时肾脏和心脏中的mRNA水平;以及21日龄时肝脏和肾脏中的mRNA水平随着添加铁水平的增加呈线性增加(P < 0.05)。然而,仅在21日龄时肝脏和肾脏中的mRNA水平检测到铁源之间生物利用率的差异(P < 0.05)。基于21日龄肉鸡肝脏或肾脏中mRNA水平与每日日粮分析铁摄入量的多元线性回归的斜率比,相对于硫酸亚铁(100%),Fe-Met W、Fe-Prot M和Fe-Prot ES的生物利用率分别为129(P = 0.18)、164(P < 0.003)和174%(P < 0.001),或者分别为102(P = 0.95)、143(P = 0.09)和174%(P < 0.004)。这些结果表明,有机铁源的相对生物利用率与其Q值密切相关,Q值较高的有机铁源显示出较高的铁生物利用率。